Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A team of researchers is studying how online video conferencing can put a virtual doctor into methadone clinics to deliver hep C treatment.
A roundup of the major presentations on HIV science at the international conference held July 22 to 28 outlines many exciting developments.
HIV Modernization Movement-Indiana (HMM) operates under three guiding principles.
The accompanying editorial and press release to recent PARTNER study findings spark concerns from the Prevention Access Campaign.
Two anonymous men share their experiences being newly diagnosed.
Plus: An interview with the documentary’s director, Daniel F. Cardone
For those with advanced liver disease, treatment for hepatitis C is more complex. But the new treatments offer considerable hope as well.
Why LGBT people, sex workers and injection drug users must be part of the discussion on ending AIDS.
POZ talks with the legendary singer about what drives her fervent activism and why she can’t stop shouting.
June 6 webinars offering technical assistance for applicants seeking funding for programs for HIV/HCV coinfected people of color
The manager of pop singer Sia chats with POZ contributing writer Shawn Decker.
Probuphine promises to deliver six months of continuous buprenorphine treatment. What does this mean for the future of the opioid epidemic?
A look at some science-based facts about HIV that may surprise you as we mark the 35th anniversary of the start of the AIDS epidemic.
The big news from the recent European liver conference.
New research suggests that the United States’ dismally low rate of viral suppression may have been quite the underestimate.
Research suggests that some people are taking hep C therapy for longer periods than they actually need.